200 related articles for article (PubMed ID: 27888623)
1. Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.
Xing P; Zhang J; Yan Z; Zhao G; Li X; Wang G; Yang Y; Zhao J; Xing R; Teng S; Ma Y; Liao Z; Ren Z; Zhang C; Han X; Zhang W; Chen K; Wang P; Yang J
Oncotarget; 2017 May; 8(22):36716-36727. PubMed ID: 27888623
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of endostar® combined with chemotherapy in patients with advanced soft tissue sarcomas.
Zhang LP; Liao XY; Xu YM; Yan LJ; Yan GF; Wang XX; Duan YZ; Sun JG
Asian Pac J Cancer Prev; 2013; 14(7):4255-9. PubMed ID: 23991986
[TBL] [Abstract][Full Text] [Related]
3. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas.
Liao Z; Zhang C; Yang T; Liu H; Yang S; Li T; Xing R; Teng S; Yang Y; Zhao J; Zhao G; Bai X; Zhu L; Yang J
Front Oncol; 2021; 11():778774. PubMed ID: 35047396
[TBL] [Abstract][Full Text] [Related]
5. Rh-endostatin Concomitant with Chemotherapy Versus Single Agent Chemotherapy for Treating Soft Tissue and Bone Sarcomas: A Systematic Review and Meta-Analysis.
Ma Z; Guo L; Cui X; Liu H; Liu L
J Pharm Pharm Sci; 2018; 21(1):386-397. PubMed ID: 30352660
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
Lu S; Li L; Luo Y; Zhang L; Wu G; Chen Z; Huang C; Guo S; Zhang Y; Song X; Yu Y; Zhou C; Li W; Liao M; Li B; Xu L; Chen P; Hu C; Hu C
J Thorac Oncol; 2015 Jan; 10(1):206-11. PubMed ID: 25654728
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study.
Hara H; Kawamoto T; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Nishida K; Kuroda R; Akisue T
BMC Cancer; 2019 Jul; 19(1):725. PubMed ID: 31337342
[TBL] [Abstract][Full Text] [Related]
8. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the combination of endostar with chemotherapy on stage IVb and recurrent metastatic cervical cancer.
Guo F; Chen C; Liang Y; Ma S; Zou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1412-1418. PubMed ID: 33472996
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective study on the efficacy and safety of low dose apatinib in reversing chemotherapy resistance in sarcoma].
Ye T; Yuan SY; Fan L; Feng LW; Chen YT; Chen J
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2435-2440. PubMed ID: 36000372
[No Abstract] [Full Text] [Related]
11. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
[No Abstract] [Full Text] [Related]
12. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of Recombinant Human Endostatin in Postoperative Early Complementary Therapy on Patients with Non-small Cell Lung Cancer in Chinese Mainland.
Zhu Q; Zang Q; Jiang ZM; Wang W; Cao M; Su GZ; Zhen TC; Zhang XT; Sun NB; Zhao C
Asian Pac J Cancer Prev; 2015; 16(9):4013-8. PubMed ID: 25987078
[TBL] [Abstract][Full Text] [Related]
14. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
An J; Lv W
Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
[TBL] [Abstract][Full Text] [Related]
15. A role for maintenance therapy in managing sarcoma.
Ray-Coquard I; Le Cesne A
Cancer Treat Rev; 2012 Aug; 38(5):368-78. PubMed ID: 21843915
[TBL] [Abstract][Full Text] [Related]
16. Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).
Penel-Page M; Ray-Coquard I; Larcade J; Girodet M; Bouclier L; Rogasik M; Corradini N; Entz-Werle N; Brugieres L; Domont J; Lervat C; Piperno-Neumann S; Pacquement H; Bay JO; Gentet JC; Thyss A; Chaigneau L; Narciso B; Cornille H; Blay JY; Marec-Bérard P
BMC Cancer; 2015 Nov; 15():854. PubMed ID: 26541413
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
18. Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer.
Yang H; Sui Y; Guo X; Tan X; Li Y; Wang M
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1148-S1151. PubMed ID: 30539861
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
Guo GF; Xia LP; Qiu HJ; Xu RH; Zhang B; Jiang WQ; Zhou FF; Wang F
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):777-81. PubMed ID: 21163071
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]